The settlement also bars Allergan and its subsidiaries from selling opioids in New York for the next decade. Allergan, best known for making Botox, discontinued its branded opioids business in 2020, a spokesperson for AbbVie, Allergan’s parent company, told The New York Times.
The agreement is part of sweeping opioids litigation that New York state and two counties filed against drugmakers, distributors and pharmacy chains in June.
Several companies, including Johnson & Johnson and CVS Health, have already inked settlements with New York. Teva Pharmaceuticals and its subsidiary Anda are the two remaining defendants in the case.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
